Suchergebnisse - "Verkleij, Christie P M"

PubPharm (16)

1

Teclistamab impairs humoral immunity in patients with heavily pretreated myeloma : importance of immunoglobulin supplementation

enthalten in: Blood advances | 2024

von Frerichs, K. | Verkleij, C. | Mateos, M. | +21

2

T-cell redirecting bispecific and trispecific antibodies in multiple myeloma beyond BCMA

enthalten in: Current opinion in oncology | 2023

von van de Donk, N. | O'Neill, C. | de Ruijter, M. | +2

3

NK Cell Phenotype Is Associated With Response and Resistance to Daratumumab in Relapsed/Refractory Multiple Myeloma

enthalten in: HemaSphere | 2023

von Verkleij, C. | Frerichs, K. | Broekmans, M. | +24

4

Redirecting T-cell Activity with Anti-BCMA/Anti-CD3 Bispecific Antibodies in Chronic Lymphocytic Leukemia and Other B-cell Lymphomas

enthalten in: Cancer research communications | 2022

von Martens, A. | Rietveld, J. | de Boer, R. | +12

5

Efficacy and safety of daratumumab combined with all-trans retinoic acid in relapsed/refractory multiple myeloma

enthalten in: Blood advances | 2021

von Frerichs, K. | Minnema, M. | Levin, M. | +11

6

Monitoring the M-protein of multiple myeloma patients treated with a combination of monoclonal antibodies : the laboratory solution to eliminate interference

enthalten in: Clinical chemistry and laboratory medicine | 2021

von Noori, S. | Verkleij, C. | Zajec, M. | +8

7

Current State of the Art and Prospects of T Cell-Redirecting Bispecific Antibodies in Multiple Myeloma

enthalten in: Journal of clinical medicine | 2021

von Hosny, M. | Verkleij, C. | van der Schans, J. | +4

8

Monitoring the M-protein of multiple myeloma patients treated with a combination of monoclonal antibodies: the laboratory solution to eliminate interference

enthalten in: Clinical chemistry and laboratory medicine | 2021

von Noori, S. | Verkleij, C. | Zajec, M. | +8

9

Monitoring the M-protein of multiple myeloma patients treated with a combination of monoclonal antibodies: the laboratory solution to eliminate interference

enthalten in: Clinical chemistry and laboratory medicine | 2021

von Noori, S. | Verkleij, C. | Zajec, M. | +8

10

Efficacy and Safety of Durvalumab Combined with Daratumumab in Daratumumab-Refractory Multiple Myeloma Patients

enthalten in: Cancers | 2021

von Frerichs, K. | Verkleij, C. | Dimopoulos, M. | +6